MoneyWorks4Me

A fair growth of 24.56% in the revenue at Rs. 1736.10 millions was reported in the March 2025 quarter as compared to Rs. 1393.80 millions during year-ago period.The Company has registered profit of Rs. 865.00  millions for the quarter ended March 2025, a growth of 23.78%  over Rs. 698.80 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended March 2025 rose to 1162.90 millions as compared to 938.60 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1736.10 1393.80 24.56 7524.10 6250.90 20.37 7524.10 6250.90 20.37
Other Income 412.50 361.80 14.01 1345.90 1058.40 27.16 1345.90 1058.40 27.16
PBIDT 1162.90 938.60 23.90 4665.60 3929.20 18.74 4665.60 3929.20 18.74
Interest 0.40 0.20 100.00 1.20 1.00 20.00 1.20 1.00 20.00
PBDT 1162.50 938.40 23.88 4664.40 3928.20 18.74 4664.40 3928.20 18.74
Depreciation 60.90 69.30 -12.12 247.70 270.80 -8.53 247.70 270.80 -8.53
PBT 1101.60 869.10 26.75 4416.70 3657.40 20.76 4416.70 3657.40 20.76
TAX 236.60 170.30 38.93 1021.80 820.30 24.56 1021.80 820.30 24.56
Deferred Tax 0.30 -1.90 -115.79 -7.20 -40.90 -82.40 -7.20 -40.90 -82.40
PAT 865.00 698.80 23.78 3394.90 2837.10 19.66 3394.90 2837.10 19.66
Equity 152.00 151.90 0.07 152.00 151.90 0.07 152.00 151.90 0.07
PBIDTM(%) 66.98 67.34 -0.53 62.01 62.86 -1.35 62.01 62.86 -1.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..